Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05457218
What this trial is testing

Effect of Insect-derived Protein Supplements on Protein Synthesis and mTORC1 Activation

Who this might be right for
Effect of Food Supplement
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00353301
What this trial is testing

Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Colorado, Denver 25
Testing effectiveness (Phase 2)Study completedNCT03522298
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Who this might be right for
Glioblastoma, Adult
Kazia Therapeutics Limited 30
Early research (Phase 1)Study completedNCT03696355
What this trial is testing

Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 27
Post-approval studies (Phase 4)Study completedNCT01206764
What this trial is testing

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 143
Not applicableLooking for participantsNCT05414292
What this trial is testing

Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)

Who this might be right for
Muscle AtrophyAge-Related Sarcopenia
University of Nottingham 16
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Very early researchStudy completedNCT04200911
What this trial is testing

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

Who this might be right for
Cognitive Impairment, MildAlzheimer Disease
The University of Texas Health Science Center at San Antonio 10
Testing effectiveness (Phase 2)Study completedNCT00411619
What this trial is testing

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Children's Hospital Medical Center, Cincinnati 28
Not applicableStudy completedNCT01632605
What this trial is testing

The Vienna RAP Pilot Study

Who this might be right for
ADPKD
Medical University of Vienna 8
Early research (Phase 1)Study completedNCT01596140
What this trial is testing

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

Who this might be right for
Advanced CancerSolid Tumor
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT00877773
What this trial is testing

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 44
Early research (Phase 1)Study completedNCT01152801
What this trial is testing

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 64
Not applicableUnknownNCT03486366
What this trial is testing

Application of Novel Diagnostic and Therapeutical Methods in Epilepsy and Neurodevelopmental Abnormalities in Children.

Who this might be right for
Epilepsy
Medical University of Warsaw 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05103358
What this trial is testing

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Who this might be right for
TumorTumor, SolidMetastasis+18 more
Aadi Bioscience, Inc. 120
Large-scale testing (Phase 3)Study completedNCT01811667
What this trial is testing

Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations

Who this might be right for
Cardiovascular Abnormalities
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 19
Testing effectiveness (Phase 2)Study completedNCT03174171
What this trial is testing

Open-label Study on Treatment of Primary Aldosteronism With Everolimus

Who this might be right for
Primary Aldosteronism
University Hospital, Basel, Switzerland 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03071874
What this trial is testing

Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas

Who this might be right for
Meningioma
Massachusetts General Hospital 28
Not applicableStudy completedNCT03319173
What this trial is testing

Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation

Who this might be right for
Mild Cognitive ImpairmentMetabolic Syndrome
Bristlecone Health, Inc. 98
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07166354
What this trial is testing

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

Who this might be right for
CanitiesGrey Hair
Applied Biology, Inc. 100
Next Page